Detection of somatic beta-catenin mutations in primary pigmented nodular adrenocortical disease (PPNAD).
about
Alterations of Phosphodiesterases in Adrenocortical TumorsMEN1, MEN4, and Carney Complex: Pathology and Molecular GeneticsGenetic predisposition to peripheral nerve neoplasia: diagnostic criteria and pathogenesis of neurofibromatoses, Carney complex, and related syndromesReview paper: origin and molecular pathology of adrenocortical neoplasmsExtracellular activation of Wnt signaling through epigenetic dysregulation of Wnt inhibitory factor-1 (Wif-1) is associated with pathogenesis of adrenocortical tumor.Mouse Prkar1a haploinsufficiency leads to an increase in tumors in the Trp53+/- or Rb1+/- backgrounds and chemically induced skin papillomas by dysregulation of the cell cycle and Wnt signalingRegulation of steroidogenesis in a primary pigmented nodular adrenocortical disease-associated adenoma leading to virilization and subclinical Cushing's syndrome.Carney complex and other conditions associated with micronodular adrenal hyperplasias.How does cAMP/protein kinase A signaling lead to tumors in the adrenal cortex and other tissues?Integrated genomic analysis of nodular tissue in macronodular adrenocortical hyperplasia: progression of tumorigenesis in a disorder associated with multiple benign lesions.Adrenocortical neoplasia: evolving concepts in tumorigenesis with an emphasis on adrenal cortical carcinoma variants.A large family with Carney complex caused by the S147G PRKAR1A mutation shows a unique spectrum of disease including adrenocortical cancerActivation of cyclic AMP signaling leads to different pathway alterations in lesions of the adrenal cortex caused by germline PRKAR1A defects versus those due to somatic GNAS mutationsProgression to adrenocortical tumorigenesis in mice and humans through insulin-like growth factor 2 and β-cateninPhosphodiesterases and adrenal Cushing in mice and humans.cAMP/PKA signaling defects in tumors: genetics and tissue-specific pluripotential cell-derived lesions in human and mouse.The transcriptome that mediates increased cyclic adenosine monophosphate signaling in PRKAR1A defects and other settings.The cAMP pathway and the control of adrenocortical development and growthPKA inhibits WNT signalling in adrenal cortex zonation and prevents malignant tumour developmentCarney complex and McCune Albright syndrome: an overview of clinical manifestations and human molecular genetics.Genetic aspects of adrenocortical tumours and hyperplasias.Steroidogenesis-adrenal cell signal transduction.Adrenocortical growth and cancer.Cell signaling pathways in the adrenal cortex: Links to stem/progenitor biology and neoplasia.WNT/β-catenin signalling is activated in aldosterone-producing adenomas and controls aldosterone production.Rare diseases in clinical endocrinology: a taxonomic classification system.Constitutive beta-catenin activation induces adrenal hyperplasia and promotes adrenal cancer development.Cushing Syndrome in Carney Complex: Clinical, Pathologic, and Molecular Genetic Findings in the 17 Affected Mayo Clinic Patients.Cushing's syndrome in an infant secondary to malignant adrenocortical tumors with somatic mutation of beta-catenin.Adrenocortical carcinoma
P2860
Q28066278-9D51D4A4-97EF-42EF-BFA8-D45F183E9FA9Q28088746-9DE8492B-CD4A-4332-912E-CBDEB1BA74F3Q30454537-2AF35B24-B72B-4BA1-A833-7F30E809212CQ33612954-F0111936-BD21-42F8-A272-046B444E0D3DQ33688573-4AFB907D-F519-4512-BC7D-A6B0C1CA0BEDQ33755811-3BD23746-A08D-4D28-9BB3-137DFB199422Q33909917-325115B4-1182-4FCA-8047-70EEFF6C297BQ34398710-CDE8F19D-ED25-4392-9A99-C34823B060EDQ34629130-C54D4413-0561-41F1-A0AA-7EF28548B25BQ34758599-D4E95DDA-629E-442C-B6E1-319AAEEB3F41Q35700559-D6701F0B-DCAB-4F70-9E07-6DB70ABF9306Q35744501-C3484031-A6C1-4B6B-AE22-3CE6C65472F0Q35869529-601EED3A-3728-44DE-85D1-5554E4D62922Q36204172-7F2C0116-9B14-488C-9941-91406D086C03Q36514530-A6D566C8-D0A4-487F-A485-D2EDDE4104FEQ36763148-DDF08CB8-452F-4482-BD7B-7D04C17E9186Q36838955-2B8FA194-F6C8-474F-A311-EFA7AF29F10BQ36918111-398C5778-E953-4349-B1AD-CB7B22525646Q37263731-D049CBBD-5DBB-4DB8-8AE8-0749B6C69E05Q37619451-CAFBBC36-1ECC-4FC3-9C34-C09C1591858DQ37999464-1CEC6D5D-785B-48F8-ABC4-841C0202E0D2Q38221447-B40AF2C7-62F8-4319-8068-BB6E361BA04FQ38318638-55DBCB83-9345-4AE2-BF8D-022973D1CE32Q39035325-C268F0E2-EE9F-4243-9B2D-554C03D16FECQ39088795-68FA5C61-AB61-4706-8AD2-E5E93DF2870AQ39102141-1A5B606A-6BC1-40EF-83C8-67D55ACBA603Q43182598-E2AA617B-4083-413E-99C5-6B1E8F5D15ECQ51310682-5ADCAFA5-D717-40C4-97F6-96BD4D25E4DDQ53305255-27042B40-3DE8-4F2B-93ED-62123EFE7B2FQ57645859-9F2575F6-73E0-4ED3-8E70-E73B4F5837EE
P2860
Detection of somatic beta-catenin mutations in primary pigmented nodular adrenocortical disease (PPNAD).
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Detection of somatic beta-cate ...... drenocortical disease (PPNAD).
@ast
Detection of somatic beta-cate ...... drenocortical disease (PPNAD).
@en
type
label
Detection of somatic beta-cate ...... drenocortical disease (PPNAD).
@ast
Detection of somatic beta-cate ...... drenocortical disease (PPNAD).
@en
prefLabel
Detection of somatic beta-cate ...... drenocortical disease (PPNAD).
@ast
Detection of somatic beta-cate ...... drenocortical disease (PPNAD).
@en
P2093
P2860
P1476
Detection of somatic beta-cate ...... drenocortical disease (PPNAD).
@en
P2093
Anelia Horvath
Antoine Lampron
Isabelle Bourdeau
Lydia Ouadi
Mimi Tadjine
P2860
P304
P356
10.1111/J.1365-2265.2008.03273.X
P577
2008-04-14T00:00:00Z